Update on acceptances – cash tender offer for all outstanding shares in Kaydence Pharma AS.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Oslo, Norway (23 March 2021) — Reference is made to the offer letter dated 9 March 2021 (the “Offer Letter”) for the cash tender offer (the “Kaydence Offer”) by Nattopharma ASA (the “Offeror” or “Nattopharma”) to acquire 100% of the shares of Kaydence Pharma AS, with organization number 919 864 559 ("Kaydence Pharma") at an offer price of NOK 5 per Share ("Offer Price"). Shareholders holding 2 288 587 shares in